Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05527899 · ClinicalTrials.gov registry record · Phase 2
Zinc Intervention in Elderly for Prevention of Pneumonia
A Phase 2 study, sponsored by Tufts University.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT05527899 is a Phase 2 study that has completed, run by Tufts University. The registered enrollment target is 105 participants.
The verdict
NCT05527899, a Phase 2 study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
Pneumonia is a major public health problem for the elderly and is one of the leading causes of hospitalization and death for this population, particularly for elderly nursing home residents. This planning grants seeks to establish a safe and effective dose of zinc supplementation with the goal to conduct a larger randomized clinical trial to study the effect of zinc supplementation in nursing home elderly with low serum zinc levels on the risk, antibiotic use, and duration of sick days with pneumonia. This project has significant potential to positively impact the health and quality of life in the elderly and to reduce the economic costs associated with their care.
Interventions
- DRUG Zinc gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2024-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05527899
The ClinicalTrials.gov registry entry for NCT05527899 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc gluconate is the first listed.
NCT05527899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05527899 about?
NCT05527899 is a clinical study titled "Zinc Intervention in Elderly for Prevention of Pneumonia". Pneumonia is a major public health problem for the elderly and is one of the leading causes of hospitalization and death for this population, particularly for elderly nursing home residents. This planning grants seeks to establish a safe and effective dose of zinc supplementation with the goal to co...
What is the current status of trial NCT05527899?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2022-05-03. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05527899?
The interventions under investigation include: Zinc gluconate (DRUG).
Who is sponsoring clinical trial NCT05527899?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.